th Update on Fabry Nephropathy : Biomarkers , Progression and Treatment Opportunities June


s Nephron 2015;130:77–91 DOI: 10.1159/000431051 82 0.882–1.0; specificity 0.75–1.0; positive predictive value 0.875–1.0; negative predictive value 0.75–1.0). In Study 011, subjects with amenable mutations randomized to migalastat demonstrated statistically significant (±SEM) decreases in the number of kidney GL-3 inclusions per capillary (IPC) (–0.25±0.10… (More)

3 Figures and Tables


  • Presentations referencing similar topics